Wynne Aherne
Papers
1
Total Citations
16
H-Index
1
About
Wynne Aherne is a distinguished researcher in chemical biology and drug discovery, with a primary focus on the development and application of high-throughput screening assays for identifying small molecule inhibitors of kinases and other therapeutic targets. Her most cited work, "High-Throughput Screening Assay for Identification of Small Molecule Inhibitors of Aurora2/STK15 Kinase" (2004, 16 citations), exemplifies her contributions to cancer research by enabling the rapid identification of potential drugs targeting the Aurora2/STK15 kinase, a key regulator of mitosis often overexpressed in tumors. This assay has been instrumental in advancing early-stage drug discovery, providing a robust platform for screening compound libraries. Aherne’s impact lies in bridging basic science and translational medicine, with her methodologies widely adopted in academic and pharmaceutical settings. Her work underscores a commitment to accelerating the pipeline from target identification to preclinical candidates, making her a pivotal figure in the fight against cancer.
Research Focus
Key Achievements
Top Papers
- 1